299 related articles for article (PubMed ID: 8838190)
21. Amphotericin B and fluconazole, a potent combination therapy for cryptococcal meningitis.
Larsen RA; Bauer M; Thomas AM; Graybill JR
Antimicrob Agents Chemother; 2004 Mar; 48(3):985-91. PubMed ID: 14982793
[TBL] [Abstract][Full Text] [Related]
22. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment.
Gupta C; Dogra P; Jain V; Kaur R; Sharma JB
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116217. PubMed ID: 38513558
[TBL] [Abstract][Full Text] [Related]
23. Correlation of fluconazole MICs with clinical outcome in cryptococcal infection.
Aller AI; Martin-Mazuelos E; Lozano F; Gomez-Mateos J; Steele-Moore L; Holloway WJ; Gutiérrez MJ; Recio FJ; Espinel-Ingroff A
Antimicrob Agents Chemother; 2000 Jun; 44(6):1544-8. PubMed ID: 10817706
[TBL] [Abstract][Full Text] [Related]
24. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
[TBL] [Abstract][Full Text] [Related]
25. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
Sar B; Monchy D; Vann M; Keo C; Sarthou JL; Buisson Y
J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027
[TBL] [Abstract][Full Text] [Related]
26. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
[TBL] [Abstract][Full Text] [Related]
27. Early mycological treatment failure in AIDS-associated cryptococcal meningitis.
Robinson PA; Bauer M; Leal MA; Evans SG; Holtom PD; Diamond DA; Leedom JM; Larsen RA
Clin Infect Dis; 1999 Jan; 28(1):82-92. PubMed ID: 10028076
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Córdoba S; Isla MG; Szusz W; Vivot W; Altamirano R; Davel G
Mycoses; 2016 Jun; 59(6):351-6. PubMed ID: 26865081
[TBL] [Abstract][Full Text] [Related]
29. Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis.
Armengou A; Porcar C; Mascaró J; García-Bragado F
Clin Infect Dis; 1996 Dec; 23(6):1337-8. PubMed ID: 8953097
[No Abstract] [Full Text] [Related]
30. Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.
Hope W; Stone NRH; Johnson A; McEntee L; Farrington N; Santoro-Castelazo A; Liu X; Lucaci A; Hughes M; Oliver JD; Giamberardino C; Mfinanga S; Harrison TS; Perfect JR; Bicanic T
mBio; 2019 Dec; 10(6):. PubMed ID: 31796539
[TBL] [Abstract][Full Text] [Related]
31. The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans.
Hai TP; Van AD; Ngan NTT; Nhat LTH; Lan NPH; Vinh Chau NV; Thwaites GE; Krysan D; Day JN
Mycoses; 2019 Sep; 62(9):818-825. PubMed ID: 31173410
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis.
Nguyen MH; Najvar LK; Yu CY; Graybill JR
Antimicrob Agents Chemother; 1997 May; 41(5):1120-3. PubMed ID: 9145879
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS.
Mayanja-Kizza H; Oishi K; Mitarai S; Yamashita H; Nalongo K; Watanabe K; Izumi T; Ococi-Jungala ; Augustine K; Mugerwa R; Nagatake T; Matsumoto K
Clin Infect Dis; 1998 Jun; 26(6):1362-6. PubMed ID: 9636863
[TBL] [Abstract][Full Text] [Related]
34. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.
Casadevall A; Spitzer ED; Webb D; Rinaldi MG
Antimicrob Agents Chemother; 1993 Jun; 37(6):1383-6. PubMed ID: 8328793
[TBL] [Abstract][Full Text] [Related]
35. Clinical and laboratory features of cryptococcal meningitis in HIV-AIDS patients.
Deo S
J Assoc Physicians India; 1995 Oct; 43(10):724. PubMed ID: 8773019
[No Abstract] [Full Text] [Related]
36. Fluconazole-resistant Cryptococcus neoformans var gattii in an AIDS patient.
Peetermans W; Bobbaers H; Verhaegen J; Vandepitte J
Acta Clin Belg; 1993; 48(6):405-9. PubMed ID: 8128821
[TBL] [Abstract][Full Text] [Related]
37. In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis.
Larsen RA; Bauer M; Brouwer AE; Sanchez A; Thomas AM; Rajanuwong A; Chierakul W; Peacock SJ; Day N; White NJ; Rinaldi MG; Harrison TS
Antimicrob Agents Chemother; 2007 Jan; 51(1):343-5. PubMed ID: 17060519
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.
Sudan A; Livermore J; Howard SJ; Al-Nakeeb Z; Sharp A; Goodwin J; Gregson L; Warn PA; Felton TW; Perfect JR; Harrison TS; Hope WW
Antimicrob Agents Chemother; 2013 Jun; 57(6):2793-800. PubMed ID: 23571544
[TBL] [Abstract][Full Text] [Related]
39. Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis.
Larsen RA; Bauer M; Weiner JM; Diamond DM; Leal ME; Ding JC; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1996 Sep; 40(9):2178-82. PubMed ID: 8878602
[TBL] [Abstract][Full Text] [Related]
40. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
